SBS On the Money: CEO SERIES: ResMed reports as the ASX plunges

Medical device maker Resmed reports its earnings and signals potential partnerships with big tech. Rhayna Bosch talks to ResMed CEO Mick Farrell. Meanwhile – global share markets come crashing down – and Mahjabeen Zaman, the head of FX Researxch at ANZ Babnk says the ASX200 is clocking its WORST single trading day in 16 months.